Literature DB >> 23177320

Stroma-derived interleukin-34 controls the development and maintenance of langerhans cells and the maintenance of microglia.

Melanie Greter1, Iva Lelios1, Miriam Merad2,3,4, Burkhard Becher1, Pawel Pelczar5, Guillaume Hoeffel6, Jeremy Price2,3, Marylene Leboeuf2,3, Thomas M Kündig7, Karl Frei8, Florent Ginhoux6.   

Abstract

Colony stimulating factor-1 (Csf-1) receptor and its ligand Csf-1 control macrophage development, maintenance, and function. The development of both Langerhans cells (LCs) and microglia is highly dependent on Csf-1 receptor signaling but independent of Csf-1. Here we show that in both mice and humans, interleukin-34 (IL-34), an alternative ligand for Csf-1 receptor, is produced by keratinocytes in the epidermis and by neurons in the brain. Mice lacking IL-34 displayed a marked reduction of LCs and a decrease of microglia, whereas monocytes, dermal, and lymphoid tissue macrophages and DCs were unaffected. We identified IL-34 as a nonredundant cytokine for the development of LCs during embryogenesis as well as for their homeostasis in the adult skin. Whereas inflammation-induced repopulation of LCs appears to be dependent on Csf-1, once inflammation is resolved, LC survival is again IL-34-dependent. In contrast, microglia and their yolk sac precursors develop independently of IL-34 but rely on it for their maintenance in the adult brain.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23177320      PMCID: PMC4291117          DOI: 10.1016/j.immuni.2012.11.001

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  28 in total

Review 1.  Psoriasis.

Authors:  Gayathri K Perera; Paola Di Meglio; Frank O Nestle
Journal:  Annu Rev Pathol       Date:  2011-11-04       Impact factor: 23.472

2.  Functional overlap but differential expression of CSF-1 and IL-34 in their CSF-1 receptor-mediated regulation of myeloid cells.

Authors:  Suwen Wei; Sayan Nandi; Violeta Chitu; Yee-Guide Yeung; Wenfeng Yu; Minmei Huang; Lewis T Williams; Haishan Lin; E Richard Stanley
Journal:  J Leukoc Biol       Date:  2010-05-26       Impact factor: 4.962

3.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.

Authors:  Yihua Cai; Xiaoyan Shen; Chuanlin Ding; Chunjian Qi; Kejia Li; Xia Li; Venkatakrishna R Jala; Huang-ge Zhang; Tian Wang; Jie Zheng; Jun Yan
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

4.  IL-34 and M-CSF share the receptor Fms but are not identical in biological activity and signal activation.

Authors:  T Chihara; S Suzu; R Hassan; N Chutiwitoonchai; M Hiyoshi; K Motoyoshi; F Kimura; S Okada
Journal:  Cell Death Differ       Date:  2010-05-21       Impact factor: 15.828

5.  Langerhans cells are not required for epidermal Vgamma3 T cell homeostasis and function.

Authors:  Sylvie Taveirne; Veerle De Colvenaer; Tina Van Den Broeck; Els Van Ammel; Clare L Bennett; Tom Taghon; Bart Vandekerckhove; Jean Plum; Björn E Clausen; Daniel H Kaplan; Georges Leclercq
Journal:  J Leukoc Biol       Date:  2011-04-12       Impact factor: 4.962

6.  An antibody against the colony-stimulating factor 1 receptor depletes the resident subset of monocytes and tissue- and tumor-associated macrophages but does not inhibit inflammation.

Authors:  Kelli P A MacDonald; James S Palmer; Stephen Cronau; Elke Seppanen; Stuart Olver; Neil C Raffelt; Rachel Kuns; Allison R Pettit; Andrew Clouston; Brandon Wainwright; Dan Branstetter; Jeffrey Smith; Raymond J Paxton; Douglas Pat Cerretti; Lynn Bonham; Geoffrey R Hill; David A Hume
Journal:  Blood       Date:  2010-08-03       Impact factor: 22.113

7.  Interleukin-34 selectively enhances the neuroprotective effects of microglia to attenuate oligomeric amyloid-β neurotoxicity.

Authors:  Tetsuya Mizuno; Yukiko Doi; Hiroyuki Mizoguchi; Shijie Jin; Mariko Noda; Yoshifumi Sonobe; Hideyuki Takeuchi; Akio Suzumura
Journal:  Am J Pathol       Date:  2011-08-26       Impact factor: 4.307

8.  Skin-resident murine dendritic cell subsets promote distinct and opposing antigen-specific T helper cell responses.

Authors:  Botond Z Igyártó; Krystal Haley; Daniela Ortner; Aleh Bobr; Maryam Gerami-Nejad; Brian T Edelson; Sandra M Zurawski; Bernard Malissen; Gerard Zurawski; Judith Berman; Daniel H Kaplan
Journal:  Immunity       Date:  2011-07-21       Impact factor: 31.745

9.  Pivotal Advance: Avian colony-stimulating factor 1 (CSF-1), interleukin-34 (IL-34), and CSF-1 receptor genes and gene products.

Authors:  Valerie Garceau; Jacqueline Smith; Ian R Paton; Megan Davey; Mario A Fares; David P Sester; David W Burt; David A Hume
Journal:  J Leukoc Biol       Date:  2010-01-05       Impact factor: 4.962

10.  Pretransplant CSF-1 therapy expands recipient macrophages and ameliorates GVHD after allogeneic hematopoietic cell transplantation.

Authors:  Daigo Hashimoto; Andrew Chow; Melanie Greter; Yvonne Saenger; Wing-Hong Kwan; Marylene Leboeuf; Florent Ginhoux; Jordi C Ochando; Yuya Kunisaki; Nico van Rooijen; Chen Liu; Takanori Teshima; Peter S Heeger; E Richard Stanley; Paul S Frenette; Miriam Merad
Journal:  J Exp Med       Date:  2011-05-02       Impact factor: 14.307

View more
  222 in total

Review 1.  Duality at the gate: Skin dendritic cells as mediators of vaccine immunity and tolerance.

Authors:  Christopher J Nirschl; Niroshana Anandasabapathy
Journal:  Hum Vaccin Immunother       Date:  2016       Impact factor: 3.452

Review 2.  Microglia in Health and Disease.

Authors:  Richard M Ransohoff; Joseph El Khoury
Journal:  Cold Spring Harb Perspect Biol       Date:  2015-09-09       Impact factor: 10.005

3.  CSF-1-dependant donor-derived macrophages mediate chronic graft-versus-host disease.

Authors:  Kylie A Alexander; Ryan Flynn; Katie E Lineburg; Rachel D Kuns; Bianca E Teal; Stuart D Olver; Mary Lor; Neil C Raffelt; Motoko Koyama; Lucie Leveque; Laetitia Le Texier; Michelle Melino; Kate A Markey; Antiopi Varelias; Christian Engwerda; Jonathan S Serody; Baptiste Janela; Florent Ginhoux; Andrew D Clouston; Bruce R Blazar; Geoffrey R Hill; Kelli P A MacDonald
Journal:  J Clin Invest       Date:  2014-08-26       Impact factor: 14.808

Review 4.  Microglia in prion diseases.

Authors:  Adriano Aguzzi; Caihong Zhu
Journal:  J Clin Invest       Date:  2017-07-17       Impact factor: 14.808

Review 5.  Microglial phenotype and adaptation.

Authors:  B J L Eggen; D Raj; U-K Hanisch; H W G M Boddeke
Journal:  J Neuroimmune Pharmacol       Date:  2013-07-25       Impact factor: 4.147

6.  IL-34-Dependent Intrarenal and Systemic Mechanisms Promote Lupus Nephritis in MRL-Faslpr Mice.

Authors:  Yukihiro Wada; Hilda M Gonzalez-Sanchez; Julia Weinmann-Menke; Yasunori Iwata; Amrendra K Ajay; Myriam Meineck; Vicki R Kelley
Journal:  J Am Soc Nephrol       Date:  2019-01-08       Impact factor: 10.121

7.  Opposing Roles of Dendritic Cell Subsets in Experimental GN.

Authors:  Sebastian Brähler; Bernd H Zinselmeyer; Saravanan Raju; Maximilian Nitschke; Hani Suleiman; Brian T Saunders; Michael W Johnson; Alexander M C Böhner; Susanne F Viehmann; Derek J Theisen; Nicole M Kretzer; Carlos G Briseño; Konstantin Zaitsev; Olga Ornatsky; Qing Chang; Javier A Carrero; Jeffrey B Kopp; Maxim N Artyomov; Christian Kurts; Kenneth M Murphy; Jeffrey H Miner; Andrey S Shaw
Journal:  J Am Soc Nephrol       Date:  2017-12-07       Impact factor: 10.121

8.  Lymphatic Endothelial Cells Are Essential Components of the Subcapsular Sinus Macrophage Niche.

Authors:  Isabelle Mondor; Myriam Baratin; Marine Lagueyrie; Lisa Saro; Sandrine Henri; Rebecca Gentek; Delphine Suerinck; Wolfgang Kastenmuller; Jean X Jiang; Marc Bajénoff
Journal:  Immunity       Date:  2019-04-30       Impact factor: 31.745

Review 9.  Macrophages: gatekeepers of tissue integrity.

Authors:  Yonit Lavin; Miriam Merad
Journal:  Cancer Immunol Res       Date:  2013-10       Impact factor: 11.151

10.  Environment drives selection and function of enhancers controlling tissue-specific macrophage identities.

Authors:  David Gosselin; Verena M Link; Casey E Romanoski; Gregory J Fonseca; Dawn Z Eichenfield; Nathanael J Spann; Joshua D Stender; Hyun B Chun; Hannah Garner; Frederic Geissmann; Christopher K Glass
Journal:  Cell       Date:  2014-12-04       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.